These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15456363)

  • 1. [Invasive aspergillosis: clinical manifestations and treatment].
    Lumbreras C; Gavaldá J
    Rev Iberoam Micol; 2003 Sep; 20(3):79-89. PubMed ID: 15456363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS-aspergillosis: are there new treatment options?
    Schwartz S; Thiel E
    Mycoses; 2003; 46 Suppl 2():8-14. PubMed ID: 15055138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    Sims-McCallum RP
    Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature.
    Kaffarnik M; Utzolino S; Blaich A; Hopt UT
    Mycoses; 2008 Jan; 51(1):74-8. PubMed ID: 18076600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral aspergillosis in the critically ill: two cases of successful medical treatment.
    Ehrmann S; Bastides F; Gissot V; Mercier E; Magro P; Bailly E; Legras A
    Intensive Care Med; 2005 May; 31(5):738-42. PubMed ID: 15782314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antifungal therapy for invasive aspergillosis.
    Cesaro S; Visintin G
    Clin Infect Dis; 2005 Apr; 40(7):1073-5; author reply 1075-6. PubMed ID: 15825015
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated invasive aspergillosis in a patient with acute leukaemia.
    Gottfredsson M; Steingrímsdóttir H
    Acta Biomed; 2006; 77 Suppl 2():10-3. PubMed ID: 16918060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin.
    Santos RP; Sánchez PJ; Mejias A; Benjamin DK; Walsh TJ; Patel S; Jafri HS
    Pediatr Infect Dis J; 2007 Apr; 26(4):364-6. PubMed ID: 17414408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on therapy of invasive mycoses in hematology and oncology].
    Maschmeyer G; Haas A; Böhme A
    Dtsch Med Wochenschr; 2005 Jun; 130(22):1381-4. PubMed ID: 15915381
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin.
    Cooke FJ; Terpos E; Boyle J; Rahemtulla A; Rogers TR
    Clin Microbiol Infect; 2003 Dec; 9(12):1238-41. PubMed ID: 14686991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
    Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
    Elter T; Sieniawski M; Gossmann A; Wickenhauser C; Schröder U; Seifert H; Kuchta J; Burhenne J; Riedel KD; Fätkenheuer G; Cornely OA
    Int J Antimicrob Agents; 2006 Sep; 28(3):262-5. PubMed ID: 16908120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
    van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antifungal therapy for invasive aspergillosis.
    Marr KA; Boeckh M; Carter RA; Kim HW; Corey L
    Clin Infect Dis; 2004 Sep; 39(6):797-802. PubMed ID: 15472810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Invasive aspergillosis].
    Caillot D; Mannone L; Kara-Slimane F
    Rev Prat; 2001 Apr; 51(7):731-7. PubMed ID: 11387668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for invasive aspergillosis.
    Viscoli C
    Clin Infect Dis; 2004 Sep; 39(6):803-5. PubMed ID: 15472811
    [No Abstract]   [Full Text] [Related]  

  • 19. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
    Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of newer antifungal therapies in clinical practice: what do the data tell us?
    Perfect JR
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.